ROLE OF GUANINE-NUCLEOTIDE-BINDING PROTEIN AND TYROSINE KINASE IN PLATELET-ACTIVATING-FACTOR ACTIVATION OF PHOSPHOLIPASE-C IN A431 CELLS - PROPOSAL FOR DUAL MECHANISMS
Aw. Thurston et al., ROLE OF GUANINE-NUCLEOTIDE-BINDING PROTEIN AND TYROSINE KINASE IN PLATELET-ACTIVATING-FACTOR ACTIVATION OF PHOSPHOLIPASE-C IN A431 CELLS - PROPOSAL FOR DUAL MECHANISMS, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 1106-1112
A431 cells, a human epidermoid carcinoma, possess specific [H-3]platel
et-activating factor (PAF) and [H-3]WEB 2086 binding sites indicating
the presence of PAF receptors. PAF-stimulated PLC as determined by the
increase in inositol phosphate levels. Pretreatment of A431 cells wit
h genistein, a putative tyrosine kinase inhibitor, abolished the abili
ty of PAF to activate PLC, whereas pretreatment with staurosporine, a
protein kinase C inhibitor, potentiated the ability of PAF to activate
PLC. Pretreatment of A431 cells with phorbol-12-myristate-1 3-acetate
, a protein kinase C activator, blocked PAF-stimulated PLC. Overnight
exposure of cells to pertussis toxin (PT) partially blocked the abilit
y of PAF to stimulate PLC. Based on these observations the involvement
of PT-sensitive and -insensitive guanine nucleotide-binding protein(s
) (G-protein) as well as the role of tyrosine kinase in the activation
of PLC by PAF was considered further. PT treatment of A431 cell membr
anes obliterated PAF-stimulated GTPase and indicated that PT-insensiti
ve membrane-associated G-proteins were not involved in PAF actions. In
alpha-toxin permeabilized cells, PT blocked GTP-gamma-S potentiation
of PLC activation by PAF, thus suggesting that PT-insensitive G-protei
ns were not involved in PAF activation of PLC in A431 cells. PAF stimu
lated tyrosine kinase activity as observed with the increase in radioa
ctivity associated with proteins immunoprecipitated with polyclonal an
tibodies to phosphotyrosine residues. This increase was blocked by PAF
receptor antagonists, CV 6209 and TCV 309, and by pretreatment with g
enistein. PAF also activated the phosphorylation of pp60c-src and Src
associated proteins in A431 cells. It is concluded that a dual mechani
sm for the activation of PLC by the PAF receptor operates. One mechani
sm functions through a membrane-associated PT-sensitive G-protein, whe
reas the other pathway is independent of G-protein mediation. Interest
ingly, tyrosine kinase activation is common for both mechanisms.